An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
Cedars-Sinai Medical Center
Revolution Medicines, Inc.
Bristol-Myers Squibb
University of Michigan
Hoffmann-La Roche
Boston Scientific Corporation
BeiGene
Imunon
Advaxis, Inc.
Hoffmann-La Roche
Steba Biotech S.A.
Novartis
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc.
Weill Medical College of Cornell University
Kaiser Permanente
Celgene
Revolution Medicines, Inc.
VA Office of Research and Development
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
H. Lee Moffitt Cancer Center and Research Institute
Advanced Accelerator Applications
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Yale University
Merck KGaA, Darmstadt, Germany
University of Kansas Medical Center
Exact Sciences Corporation
Eli Lilly and Company